Exploring Anti-Inflammatory Treatments for Depression

Recent research highlights the potential of anti-inflammatory drugs in treating depression linked to chronic inflammation, offering hope for targeted therapies.
Psilocybin’s Effects on Immunity and Behavior Under Varying Conditions

Recent research highlights that the effects of psilocybin can differ significantly depending on the physiological state and environment of the subject.
Enhancing Behavioral Health Data Exchange for Better Outcomes

The integration of behavioral health and physical health data is crucial for providing quality care and avoiding medication errors.
The Human Side of Layoffs: Navigating the Emotional Toll

Laying off employees is a complex emotional challenge that impacts both parties involved. Understand how to manage this process with empathy.
February 2026 APA Journals Highlight Key Psychiatric Research
Discover the new research from the American Psychiatric Association’s journals, focusing on neuroplasticity, cannabis and alcohol interactions, and more.
Investing in Recovery: The STREETS Initiative Explained
Secretary Kennedy announces a $100 million investment aimed at transforming the approach to homelessness and substance use recovery.
Funding New Paths for Addiction Recovery and Homelessness
The HHS announces a new $100M initiative focused on addiction recovery and support for the homeless, marking a shift from previous policies.
Mapping Genetic Risks to Depression-Related Brain Changes
A recent study highlights the intersection of genetic factors with brain structure and activity changes in major depressive disorder.
Cannabidiol Shows Promise in Preventing Alzheimer’s Symptoms
Cannabidiol may protect against early Alzheimer-like symptoms in rats by reducing brain inflammation.
Unique Neural Responses to Alcohol Consumption in Mice
A new study identifies specific neurons in the amygdala that show distinctive activity patterns during alcohol consumption, advancing our understanding of alcohol use disorder.